RecruitingNCT06128343
Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Sponsor
University Hospital, Toulouse
Enrollment
1,500 participants
Start Date
Nov 16, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
BACAP-2 is a prospective biobank dedicated to the pancreatic adenocarcinoma including clinical data and biological samples from tumor. The aim is to enrich the previous propective collection BACAP in order to support future research projects.
Eligibility
Min Age: 18 YearsMax Age: 120 Years
Inclusion Criteria3
- Patient with pancreatic mass syndrome explored by ultrasound endoscopy with cytopuncture or
- Patient with pancreatic mass syndrome explored by an abdominal scanner with and without injection of product contrast and/or puncture of the mass or secondary lesions by radiological route or
- Patient with pancreatic adenocarcinoma proven histologically and/or cytologically
Exclusion Criteria2
- Patient with a pancreatic tumor whose analysis histological is not an adenocarcinoma
- Pregnant or breastfeeding patient
Interventions
OTHERcollection of biological samples
Collection of biological samples including whole blood and micro-biopsy from tissue of pancreas
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06128343
Related Trials
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location
An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma
NCT074696831 location
Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer
NCT064564111 location
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
NCT0407530518 locations
Prospective Data Collection Initiative on Thoracic Malignancies
NCT0699624910 locations